Correlation Between Enliven Therapeutics and Haleon Plc
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Haleon Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Haleon Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Haleon plc, you can compare the effects of market volatilities on Enliven Therapeutics and Haleon Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Haleon Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Haleon Plc.
Diversification Opportunities for Enliven Therapeutics and Haleon Plc
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and Haleon is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Haleon plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haleon plc and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Haleon Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haleon plc has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Haleon Plc go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Haleon Plc
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Haleon Plc. In addition to that, Enliven Therapeutics is 2.61 times more volatile than Haleon plc. It trades about -0.06 of its total potential returns per unit of risk. Haleon plc is currently generating about 0.07 per unit of volatility. If you would invest 967.00 in Haleon plc on December 1, 2024 and sell it today you would earn a total of 51.00 from holding Haleon plc or generate 5.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enliven Therapeutics vs. Haleon plc
Performance |
Timeline |
Enliven Therapeutics |
Haleon plc |
Enliven Therapeutics and Haleon Plc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enliven Therapeutics and Haleon Plc
The main advantage of trading using opposite Enliven Therapeutics and Haleon Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Haleon Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haleon Plc will offset losses from the drop in Haleon Plc's long position.Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Haleon Plc vs. Teva Pharma Industries | Haleon Plc vs. Bausch Health Companies | Haleon Plc vs. Zoetis Inc | Haleon Plc vs. Takeda Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |